Dermatofibrosarcoma protuberans: treatment results of 35 cases
- PMID: 11054521
- DOI: 10.1016/s0167-8140(00)00228-0
Dermatofibrosarcoma protuberans: treatment results of 35 cases
Abstract
Background and purpose: This study evaluates the treatment results of patients with dermatofibrosarcoma protuberans.
Patients and methods: Between August 1987 and July 1998, 35 consecutive patients with pathologically proved dermatofibrosarcoma protuberans received surgery with or without radiation therapy. Their treatment results were analyzed retrospectively.
Results: The patient ages ranged from 5 to 67 years (median 37 years). There were 24 males and 11 females. The anatomic sites of tumor were: trunk in 21, extremity in eight, and head and neck region in six. The maximal dimension of tumor ranged from 1.5 to 25 cm. Surgery techniques included local excision and wide excision with or without graft or flap. Adjuvant radiation therapy was given to 11 patients, with a dose ranging from 46 to 68 Gy (one pre-operative, ten post-operative). At a median follow-up of 50 months (range 11-131 months), there were 11 patients (nine patients without radiation therapy) who developed local failure. Salvage therapy (excision with or without radiation therapy) was given to all of them, and ten achieved disease control. Some patients had treatment-related moderate cosmetic or functional problems.
Conclusions: Dermatofibrosarcoma protuberans is a malignancy of a high cure rate, and adjuvant radiation therapy can reliably decrease the local recurrence rate and prevent mutilation and functional deficit caused by repeated surgery.
Similar articles
-
Dermatofibrosarcoma protuberans: long-term outcomes of 53 patients treated with conservative surgery and radiation therapy.Int J Radiat Oncol Biol Phys. 2013 Jul 1;86(3):585-90. doi: 10.1016/j.ijrobp.2013.02.024. Epub 2013 Apr 26. Int J Radiat Oncol Biol Phys. 2013. PMID: 23628134
-
The role of radiation therapy in the management of dermatofibrosarcoma protuberans.Int J Radiat Oncol Biol Phys. 1998 Mar 1;40(4):823-7. doi: 10.1016/s0360-3016(97)00895-x. Int J Radiat Oncol Biol Phys. 1998. PMID: 9531366 Review.
-
Long-term outcomes of surgical treatment for dermatofibrosarcoma protuberans according to width of gross resection margin.J Plast Reconstr Aesthet Surg. 2016 Mar;69(3):395-401. doi: 10.1016/j.bjps.2015.10.027. Epub 2015 Oct 30. J Plast Reconstr Aesthet Surg. 2016. PMID: 26646402
-
Dermatofibrosarcoma protuberans: wide local excision vs. Mohs micrographic surgery.Cancer Treat Rev. 2008 Dec;34(8):728-36. doi: 10.1016/j.ctrv.2008.06.002. Epub 2008 Aug 5. Cancer Treat Rev. 2008. PMID: 18684568 Review.
-
Low recurrence rate after surgery for dermatofibrosarcoma protuberans: a multidisciplinary approach from a single institution.Cancer. 2004 Mar 1;100(5):1008-16. doi: 10.1002/cncr.20051. Cancer. 2004. PMID: 14983497
Cited by
-
Excellent survival of pediatric dermatofibrosarcoma protuberans in Taiwanese.Pediatr Surg Int. 2007 Mar;23(3):211-4. doi: 10.1007/s00383-006-1749-x. Epub 2006 Nov 16. Pediatr Surg Int. 2007. PMID: 17109179
-
Dermatofibrosarcoma Protuberans of the Breast in Man: An Extremely Rare Entity With a Review of the Literature.J Investig Med High Impact Case Rep. 2019 Jan-Dec;7:2324709619875634. doi: 10.1177/2324709619875634. J Investig Med High Impact Case Rep. 2019. PMID: 31522558 Free PMC article. Review.
-
Dermatofibrosarcoma Protuberans.Curr Treat Options Oncol. 2017 Aug 10;18(9):56. doi: 10.1007/s11864-017-0498-5. Curr Treat Options Oncol. 2017. PMID: 28795284 Review.
-
Cutaneous soft tissue sarcomas: survival-related factors.Arch Dermatol Res. 2022 Sep;314(7):625-631. doi: 10.1007/s00403-021-02268-1. Epub 2021 Jul 17. Arch Dermatol Res. 2022. PMID: 34272971 Review.
-
Dermatofibrosarcoma protuberans (DFSP) successfully treated with sorafenib: case report.Clin Sarcoma Res. 2013 Apr 4;3(1):5. doi: 10.1186/2045-3329-3-5. Clin Sarcoma Res. 2013. PMID: 23557478 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical